Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). (Q33757126)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). |
scientific article |
Statements
1 reference
Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT). (English)
1 reference
Jay N Cohn
1 reference
Serge Masson
1 reference
Scott Solomon
1 reference
Roberto Latini
1 reference
Inder S Anand
1 reference
Margaret Prescott
1 reference
Gianni Tognoni
1 reference
Val-Heft Investigators
1 reference
1 December 2010
1 reference
1 reference
16
1 reference
12
1 reference
964-970
1 reference
Identifiers
1 reference
1 reference